We read with interest the recent article of Kosowicz et al. [3] regarding serum reverse triiodothyronine (reverse T3) levels in patients with end-stage renal failure on conservative treatment. 9 of their 40 patients presented with the classical 'low triiodothyronine (T3) syndrome': low T3, high reverse T3, low or normal thyroxine (T4), and normal TSH serum concentrations. Similar findings have been described previously for other nonthyroidal illnesses [1]. We want to point out that the situation is different in patients with end-stage renal failure on regular hemodialy-sis treatment. Here, in fact, serum reverse T3 levels are low normal or below the normal range. In figure 1 the serum reverse T3 levels of patients with end-stage renal failure on conservative treatment (plasma creatinine above 7 mg/dl; for details of patients and methods of hormone determination see Weissel et al. [6]) are compared with those obtained in patients with end-stage renal failure on chronic hemo-dialysis treatment. The mean value of the latter group of patients is significantly decreased (Student's t test) in comparison to the value of patients on conservative treatment. 7 of the 10 patients of this group had reverse T3 serum levels below the normal range of our laboratory. Table I shows the mean values and standard deviations of total T4, total T3, and basal TSH as well as maximal TSH increments after TRH. In both groups total T4 and T3 levels were similar: T3 being below our normal range, T4 being normal or low normal. Neither basal nor TRH-stimulated TSH ¿o· 36-32-28-.24-20-group I p < 0.05 group II Fig.l . Serum reverse T3 levels in patients with end-stage renal failure on conservative treatment (group I) and in patients on chronic hemodialysis treatment (group II). Statistical comparison of the mean values of the two groups by Student's t test. Table I . Serum concentrations of thyroid hormones in patients with end-stage failure (mean ± SD)
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